Nebenwirkungen · Levetiracetam Sun
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 9–10
HOS-213381 · Präparat HOS-155098
9 Frequency category MedDRA SOC Very common Common Uncommon Rare Very rare tissue disorders phosphokinase increased(3) General Asthenia/fatig disorders and ue administration site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-05T17:50:00Z · SHA-256 f80259f0a633129e975a9f79564d138649ec314b1edc442f788673298850b8fe · Passage b44bcfc9979b55794d7d452e3c30ffd89fc25e2a3a784d77186299f132e4fb32 · Zeichen 6784–7760 im Abschnitt